RDY
Dr. Reddy's Laboratories Ltd. Sponsored ADR · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website drreddys.com
- Employees(FY) 25863
- ISIN US2561352038
Performance
-2.68%
1W
-3.06%
1M
-2.59%
3M
+10.08%
6M
+2.76%
YTD
+18.99%
1Y
Profile
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Investment Analysis Report: RDY
Overview
In this investment analysis report, we will delve into the financial statements of RDY, a pharmaceutical company operating in the Health Technology sector. We will analyze the company's Balance Sheets, Income Statements, and Cashflow Statements over the past three years to gain insights into its valuation...
Technical Analysis of RDY 2024-05-03
Overview:
In analyzing the technical indicators for RDY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Indicators:
- Moving Averages (MA): The 5-day MA has been consistently above the closing prices, i...
Recent News & Updates
- 2024-05-07 10:31
Dr. Reddy’s Q4 & Full Year FY24 Financial Results(Business Wire)
- 2024-05-07 00:54
- 2024-05-06 22:31
Dr. Reddys Q4 & Full Year FY24 Financial Results(Businesswire)
- 2024-05-03 08:00
- 2024-05-02 20:00
- 2024-03-22 07:00
- 2024-03-21 19:00
- 2024-03-19 21:40
- 2024-03-19 07:00
- 2024-03-18 19:00
- 2024-02-28 09:40
- 2024-02-05 09:50
- 2024-02-02 09:45
- 2024-02-01 11:01
- 2024-02-01 09:03
- 2024-01-31 09:44
Dr. Reddy’s Q3 & 9M FY24 Financial Results(Business Wire)
- 2024-01-30 20:44
Dr. Reddys Q3 & 9M FY24 Financial Results(Businesswire)
- 2024-01-30 14:03
Analyst Report: Dr. Reddy's Laboratories Limited(Morningstar Research)
- 2024-01-30 06:19
- 2024-01-30 05:38
- 2024-01-29 04:50
Indias Sensex Declines, Weighed by Financial Stocks(Yahoo Finance)
- 2024-01-03 06:00
- 2024-01-02 17:00
- 2023-12-14 07:49
- 2023-12-13 18:49
- 2023-12-06 07:00
- 2023-11-02 09:40
- 2023-10-30 07:38
- 2023-10-29 13:08
- 2023-10-29 01:08
Page 1 of 5
previousnext